PEAK6 Investments’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $514K | Sell |
9,730
-3,300
| -25% | -$174K | ﹤0.01% | 427 |
|
|
2024
Q2 | $706K | Buy |
13,030
+6,950
| +114% | +$377K | ﹤0.01% | 379 |
|
|
2024
Q1 | $426K | Sell |
6,080
-449
| -7% | -$31.5K | ﹤0.01% | 479 |
|
|
2023
Q4 | $545K | Sell |
6,529
-3,971
| -38% | -$332K | ﹤0.01% | 491 |
|
|
2023
Q3 | $309K | Buy |
10,500
+4,000
| +62% | +$118K | ﹤0.01% | 594 |
|
|
2023
Q2 | $212K | Buy |
+6,500
| New | +$212K | ﹤0.01% | 558 |
|
|
2023
Q1 | – | Sell |
-7,000
| Closed | -$321K | – | 1393 |
|
|
2022
Q4 | $321K | Sell |
7,000
-200
| -3% | -$9.16K | ﹤0.01% | 633 |
|
|
2022
Q3 | $349K | Buy |
7,200
+700
| +11% | +$33.9K | ﹤0.01% | 846 |
|
|
2022
Q2 | $212K | Buy |
+6,500
| New | +$212K | ﹤0.01% | 1345 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1894 |
|